Dolutegravir

CAS Number1051375-16-6
Molecular FormulaC20H19F2N3O5
Molecular Weight419.4
InChI KeyRHWKPHLQXYSBKR-BMIGLBTASA-N
LogP2.4
Synonyms
  • (3S,7R)-N-[(2,4-difluorophenyl)methyl]-11-hydroxy-7-methyl-9,12-dioxo-4-oxa-1,8-diazatricyclo[8.4.0.03,8]tetradeca-10,13-diene-13-carboxamide

Applications:

Uv-Vis Spectrum of Dolutegravir

February 17, 2026

Access the UV-Vis Spectrum SIELC Library

If you are looking for optimized HPLC method to analyze Dolutegravir check our HPLC Applications library

For optimal results in HPLC analysis, it is recommended to measure absorbance at a wavelength that matches the absorption maximum of the compound(s) being analyzed. The UV spectrum shown can assist in selecting an appropriate wavelength for your analysis. Please note that certain mobile phases and buffers may block wavelengths below 230 nm, rendering absorbance measurement at these wavelengths ineffective. If detection below 230 nm is required, it is recommended to use acetonitrile and water as low UV-transparent mobile phases, with phosphoric acid and its salts, sulfuric acid, and TFA as buffers.
For some compounds, the UV-Vis Spectrum is affected by the pH of the mobile phase. The spectra presented here are measured with an acidic mobile phase that has a pH of 3 or lower.

Application Analytes:
Dolutegravir
SIELC Technologies usually develops more than one method for each compound. Therefore, this particular method may not be the best available method from our portfolio for your specific application. Before you decide to implement this method in your research, please send us an email to research@sielc.com so we can ensure you get optimal results for your compound/s of interest.

HPLC Method for Analysis of Dolutegravir and Dolutegravir Intermediate-1 on Primesep B Column

January 10, 2025

HPLC Method for Dolutegravir, Dolutegravir Intermediate-1 on Primesep B by SIELC Technologies

HPLC Method for Analysis of Dolutegravir and Dolutegravir Intermediate-1 on Primesep B Column by SIELC Technologies


High Performance Liquid Chromatography (HPLC) Method for Analysis of Dolutegravir, Dolutegravir Intermediate-1

Dolutegravir Intermediate-1 is a key chemical precursor used in the synthesis of Dolutegravir, an antiretroviral drug for the treatment of HIV infection. This intermediate plays a crucial role in building the core structure of Dolutegravir, contributing to its integrase strand transfer inhibitor (INSTI) activity, which prevents the virus from integrating its genetic material into the host cell’s DNA. Its synthesis requires precise chemical processes to ensure high purity and yield, as it directly impacts the efficacy and safety of the final pharmaceutical product.

Dolutegravir, Dolutegravir Intermediate-1 can be retained, and analyzed using a Primesep B mixed-mode stationary phase column. The analysis utilizes a gradient method with a simple mobile phase consisting of water, acetonitrile (MeCN), and phosphoric acid as a buffer. Detection is carried out using UV.

ColumnPrimesep B, 4.6 x 150 mm, 5 µm, 100 A, dual ended
Mobile PhaseGradient MeCN 30% – 90%, 10 min
BufferH3PO4 – 0.1%
Flow Rate1 ml/min
DetectionUV 270 nm

Class of CompoundsAntiretroviral Drug
Analyzing CompoundsDolutegravir, Dolutegravir Intermediate-1

Application Column

Primesep B

Column Diameter: 4.6 mm
Column Length: 150 mm
Particle Size: 5 µm
Pore Size: 100 A
Column options: dual ended

Add to cart
Application Analytes:
Dolutegravir
Dolutegravir Intermediate-1

Application Detection:
UV Detection
SIELC Technologies usually develops more than one method for each compound. Therefore, this particular method may not be the best available method from our portfolio for your specific application. Before you decide to implement this method in your research, please send us an email to research@sielc.com so we can ensure you get optimal results for your compound/s of interest.